ALS: 5 Rules I Learned to be True

Recent Posts

• Phase 3 trial of masitinib can now launch in US, some EU countries
• What we’ve learned about ALS progression over 15 years
• FDA clears troculeucel for expanded access program
• First Hoffman award winners to expand multidisciplinary ALS care
• Access to investigational ALS therapy MN‑166 expanded further